<- Go Home

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Market Cap

DKK 108.3B

Volume

244.5K

Cash and Equivalents

DKK 1.1B

EBITDA

DKK 8.6B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

DKK 18.9B

Profit Margin

67.87%

52 Week High

DKK 810.20

52 Week Low

DKK 480.00

Dividend

4.78%

Price / Book Value

7.85

Price / Earnings

27.18

Price / Tangible Book Value

-6.62

Enterprise Value

DKK 132.3B

Enterprise Value / EBITDA

14.91

Operating Income

DKK 7.7B

Return on Equity

27.26%

Return on Assets

9.85

Cash and Short Term Investments

DKK 1.1B

Debt

DKK 25.1B

Equity

DKK 13.8B

Revenue

DKK 27.9B

Unlevered FCF

DKK 3.9B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches